Zimmer Biomet’s $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

All NewsAugust 7, 2025

Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent